10/10/2019
Mark Ralston/AFP/Getty Images

A jury in Philadelphia ordered Johnson & Johnson to pay $8 billion in punitive damages to a man who says he developed breasts after taking the company's antipsychotic drug Risperdal when he was a child. The lawsuit accused the company of marketing Risperdal for unapproved indications in children and for failing to warn potential users about the risk of gynecomastia. The company denied the allegations and said it expects the ruling to be overturned.

Full Story:
CBS News, Reuters

Related Summaries